IceCure Medical (ICCM) Liabilities and Shareholders Equity (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $13.3 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $13.3 million, up 19.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $52.9 million (down 2.69% YoY), and the FY2025 annual result was $13.9 million, up 10.43% from the prior year.
• Liabilities and Shareholders Equity eased to $13.3 million in Q1 2026 per ICCM's latest filing, from $13.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $30.2 million in Q4 2022 and troughed at $10.6 million in Q2 2025.
• A 5-year average of $18.3 million and a median of $16.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2026: Liabilities and Shareholders Equity sank 45.64% in 2023, then advanced 19.8% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $30.2 million in 2022, then sank by 45.64% to $16.4 million in 2023, then declined by 23.36% to $12.6 million in 2024, then advanced by 10.43% to $13.9 million in 2025, then declined by 4.21% to $13.3 million in 2026.
• Business Quant data shows ICCM's Liabilities and Shareholders Equity at $13.3 million in Q1 2026, $13.9 million in Q4 2025, and $15.1 million in Q3 2025.